NON METASTATIC HER2 POSITIVE BREAST CANCER
Clinical trials for NON METASTATIC HER2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new NON METASTATIC HER2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for NON METASTATIC HER2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could simplify breast cancer treatment before surgery
Disease control Recruiting nowThis study tests a drug called Phesgo, given as a shot under the skin, for women with early-stage HER2-positive breast cancer before they have surgery. About 70 women in Algeria will receive Phesgo along with standard chemotherapy for about 18 weeks. The main goal is to see how m…
Matched conditions: NON METASTATIC HER2 POSITIVE BREAST CANCER
Sponsor: Blida 1 University • Aim: Disease control
Last updated Jun 26, 2026 15:29 UTC
-
Can a simple ratio predict breast cancer treatment success?
Knowledge-focused Recruiting nowThis study looks at whether a very high level of a protein called HER2 (measured by the HER2/CEP17 ratio) affects how well breast cancer patients do after treatment with a combination of two targeted drugs (trastuzumab and pertuzumab). Researchers will review medical records of 3…
Matched conditions: NON METASTATIC HER2 POSITIVE BREAST CANCER
Sponsor: Shandong Cancer Hospital and Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC